Neurosurgical Robotics Market
Medical Device

Neurosurgical Robotics Market Growing with CAGR of 16.1% from 2022 to 2028.

Neurosurgical robots are the type of surgical robot used in the medical industry to perform various procedures related to neurological disorders. Various neurosurgical robots are used for spinal and cranial applications. Hospitals are the major end users of neurosurgical robots.

Market Dynamics

The growth of the market is defined by the key driving factors such as rise in number of neurosurgical procedures and advantages of neurosurgical robots encourage key players to develop innovative products. Additionally, rising developments of nanorobots for neurosurgery are likely to emerge as a significant future trend in the market during the forecast period. However, high installation costs of neurosurgical robots is likely to hinder the growth of the market during the forecast period.

Brainlab AG & Medtronic –are Notable Market Players in Neurosurgical Robotics Market

Competitive Landscape

Market leaders operating in the neurosurgical robotics market have undertaken various organic and inorganic growth strategies. The neurosurgical robotics market majorly consists of players such as Brainlab AG; Medtronic; Renishaw plc; Zimmer Biomet; Globus Medical, Inc.; Synaptive Medical, Inc.; NuVasive, Inc.; Accuray Incorporated; Brain Navi Biotechnology Co., Ltd.; B. Braun Melsungen; and others.

Several organic approaches, such as product launches, and expansion in the neurosurgical robotics market, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.

Below is the list of the growth strategies done by the players operating in the neurosurgical robotics market:

Year News
Jun-2022 Accuray Incorporated announced that it partnered with Limbus AI Inc. to augment Accuray adaptive radiotherapy capabilities by leveraging its artificial intelligence (AI)-driven auto contouring algorithms.
May-2022 B. Braun announced that its surgery division Aesculap secured long-term and exclusive distribution rights for the jointly developed Aesculap Aeos digital surgical microscope. The agreement was concluded between Aesculap AG and True Digital Surgery Inc (TDS).
July-2022 Globus Medical announced the first spinal surgeries with ExcelsiusGPS in Sydney were performed at Westmead Private Hospital.